Rates of venous thromboembolism (VTE) were similar in trauma patients who received enoxaparin or dalteparin during hospitalization, a study found.
The primary outcome was symptomatic, recurrent venous thromboembolism (VTE) within 90 days.
Rates of major bleeding were similar whether patients were treated to an international normalized ratio target of 1.8 or 2.5 to prevent venous thromboembolism (VTE) after hip or knee ... A lower-than-standard target international normalized ratio (INR)
For patients with an unprovoked venous thromboembolism (VTE), rivaroxaban was associated with lower risk of recurrence and similar rates of bleeding as warfarin, according to a recent study. ... warfarin. Overall, the study indicates that“ rivaroxaban
Inpatients with more severe heart failure are at higher short-term risk of venous thromboembolism (VTE) than those with less severe heart failure, an analysis found. ... heart failure who are at high risk of thromboembolism and should, therefore, be
Patients who were randomized to 45 days of rivaroxaban instead of placebo did have lower risk of nonfatal venous thromboembolism (VTE), the industry-funded trial found. ... thromboprophylaxis with appropriate selection of medically ill patients may
Researchers have devised a new algorithm to predict a patient's risk of developing venous thromboembolism (VTE) in the next five years, based on simple clinical variables. ... A guideline on the issue,“ Venous Thromboembolism Prophylaxis in
Venous thromboembolism (VTE) prophylaxis in high-risk medical service patients didn't reduce rates of symptomatic VTE in the 90 days after hospital discharge, a study found.
A feature story looks at the complicated calculations behind ICU admission decisions, while a Success Story details an effort to get patients on board with venous thromboembolism prophylaxis.
In a U.S. hospital, the low-molecular-weight heparin on the formulary was switched from enoxaparin to dalteparin and then back to enoxaparin, and venous thromboembolism (VTE) rates were compared ... Rates of venous thromboembolism (VTE) were similar in